Corrigendum to “Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028”

ESMO Open 2026 Open access

Read full text
Authors: M. Donia, H. Jespersen, M. Jalving, R. Lee, H. Eriksson, C. Hoeller, M. Hernberg, I. Gavrilova, L. Kandolf, G. Liszkay, H. Helgadottir, A. Zhukavets
+8 more Dace Pjanova, I. Marquez-Rodas, B. Neyns, Hans M. Westgeest, I. Pourmir, P. Sobczuk, E. Ellebæk, T. Amaral
DOI: 10.1016/j.esmoop.2025.105492
Cited by: 1

Fields of Study & Subjects

Cutaneous Melanoma Detection and Management Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
ESMO Open
Publisher
Elsevier BV
Volume
11
Issue
1
Pages
105492–105492
Publication date
1 January 2026
Language
EN